GI Effects Methane Dysbiosis Score Test

If you have spent years dealing with constipation that resists fiber, water, and stool softeners, your gut may be hosting an overgrowth of microbes that make methane. Methane physically slows the muscle contractions in your intestine, and a small group of single-celled organisms called archaea (different from bacteria) are responsible for almost all of the methane your body produces.

This score estimates how active those methane-making microbes are based on your stool sample. It is a newer, exploratory readout without universally agreed cutpoints, but a high reading often points toward a recognized gut condition that responds to specific treatment, even when standard stool tests look unremarkable.

What the Score Actually Reflects

Methane in your gut is not made by your own cells. It is made by methanogenic archaea, especially a microbe called Methanobrevibacter smithii (M. smithii), which converts hydrogen and carbon dioxide produced by other gut bacteria into methane gas. This process is called methanogenesis. The gas then either passes as flatus or absorbs into your blood and exits in your breath.

The GI Effects Methane Dysbiosis Score is a proprietary index built from stool DNA analysis. The exact formula is not publicly available, which is one reason this score should be read as exploratory rather than definitive. Most of the published research on methane in human gut health uses breath methane testing or direct microbe quantification rather than this specific score, so much of the supporting evidence below comes from those related but different measurements.

Why a High Score Matters

A high methane signal is the most consistent microbial pattern linked to constipation-predominant irritable bowel syndrome (IBS-C) and slow gut transit. In a study of IBS patients, those with the constipation subtype had higher copy numbers of M. smithii, which correlated with higher methane production and abdominal bloating. The clinical pattern is consistent enough that doctors now recognize a distinct condition called intestinal methanogen overgrowth (IMO).

The mechanism is not subtle. Methane gas slows the rhythmic contractions that move stool through your intestines. The more methane your microbes produce, the slower your transit tends to be. In a study of 1,461 patients tested for small intestinal bacterial overgrowth, those with the methane-positive form had clinical features distinct from the hydrogen-producing form, including a higher prevalence of constipation.

Why a Low Score Also Has Meaning

A low methane signal is not automatically a sign of good gut health. A meta-analysis comparing methane-positive overgrowth in different conditions found that people with inflammatory bowel disease (IBD), particularly Crohn's disease, had markedly lower methanogen presence than healthy controls. A study of IBS patients similarly found that the diarrhea-predominant and mixed subtypes had a reduction in methane-producing microorganisms alongside reductions in butyrate-producing bacteria, which the authors linked to excess gas and impaired gut barrier function.

This is why the score should not be read as a simple good-number-bad-number readout. It reflects a phenotype, not a verdict. Both unusually high and unusually low values can carry clinical meaning, and what they mean depends on your symptoms and what other markers show.

When Results Can Be Misleading

Several factors can distort a single reading and lead to the wrong conclusion:

• Recent antibiotics: any antibiotic course in the prior 4 to 8 weeks can suppress methanogens and other microbes, lowering the score temporarily without reflecting your true baseline.
• Acute diarrheal illness: an active gut infection or bout of food poisoning can transiently shift the entire microbial composition. Wait until your gut has returned to baseline before testing.
• Proton pump inhibitors (PPIs): observational research has shown that PPIs significantly alter gut microbiome composition, lowering gut commensal microbes and raising oral and upper gastrointestinal microbes. This shift can change a stool dysbiosis reading without indicating a methane-driven condition.
• Recent dietary extremes: a sudden switch to a very low-carbohydrate, very high-fiber, or elemental diet in the days before testing can change the substrates available for fermentation and shift gas-producing microbes.

Tracking Your Trend

A single stool reading captures one moment in a microbial ecosystem that shifts with diet, sleep, stress, illness, and medication. Because this score lacks a standardized clinical cutpoint, your own trend over time is far more useful than any one number. Repeat readings let you see whether an intervention is moving the needle on your own biology.

A reasonable cadence: get a baseline reading, retest in 8 to 12 weeks if you start a targeted intervention (antibiotic protocol, dietary change, motility-targeted treatment), and then at least annually. If you have ongoing constipation symptoms, more frequent testing during active treatment windows lets you confirm that a specific therapy is reducing methanogen activity rather than just guessing.

What to Do With an Abnormal Result

An abnormal score is a starting point, not a diagnosis. The most useful next step depends on your symptom pattern.

If your score is elevated and you have chronic constipation, bloating, or slow transit symptoms, the pattern is consistent with intestinal methanogen overgrowth. Confirming with a hydrogen-methane breath test gives you a standardized, well-validated second readout. A fasting breath methane of 10 parts per million or above has been shown in published research to correlate with fecal methanogen load and predict response to treatment. A gastroenterologist familiar with motility disorders is the right specialist to coordinate care.

If your score is unusually low and you have diarrhea, urgency, or known IBD, the pattern fits a different microbial picture. The decision pathway here is not antimicrobial treatment but evaluation for inflammatory bowel disease, which may include calprotectin testing, comprehensive stool analysis, and gastroenterology referral for endoscopy if not already done.